Dr. Dan Ackerman talks with Dr. Trey Bateman about the significance of blood-based biomarkers in Alzheimer disease.
Purchase Annual Meeting On Demand) to get access to the recordings and the ability to claim CME through March 1, 2026.
Disclosures can be found at Neurology.org).
